The Global Health Body Sounds Warning Over Acute Lack of Obesity Injections
Fewer than a tenth of individuals eligible to benefit from obesity jabs including Wegovy have access to them, warns the global health agency as it issues its initial guidance on the therapies.
Considering in excess of 1,000,000,000 people worldwide now obese, it is calling for more widespread and fairer access to this class of drugs.
According to estimates, over two billion are projected to be obese by 2030 without intervention.
"The latest guidelines affirms that obesity is a long-term condition that can be managed with comprehensive and continuous support," remarked the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and distribution challenges are major obstacles to universal access to the jabs that can aid individuals in losing considerable body mass, notes the organization.
Skinny Jab Supply Crisis
Even in the present most optimistic scenario, the production of GLP-1 therapies could only cover around 100 million people – fewer than 10% of eligible patients, as stated by the health organization.
The guideline encourages nations and manufacturers to widen availability, by approaches including voluntary licensing.
A patent on the active ingredient – the core ingredient of the drug Wegovy – is scheduled to end in several countries in 2026.
How Weight-Loss Jabs Work
The injections imitate a natural hormone to reduce digestion speed, suppress the appetite and increase the sense of being full so individuals consume fewer calories.
Individuals commonly start to lose weight after several weeks of commencing the regular doses.
Studies points to patients may put most of the weight back on a year later of halting the drug, when their normal food cravings return.
Being above a healthy weight increases your chance for contracting health problems, like diabetes, cardiovascular issues, brain attack, and specific malignancies.
Obesity concerns people in countries worldwide and was responsible for over three and a half million deaths worldwide in 2024, as per the health agency.